Skip to content

Relay Therapeutics, Inc. RLAY Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Celcuity logo
CelcuityCELC
$13K-92.3%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$16.61M+28.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$1.09M+26.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$13M+8.3%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$350K+13.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.38M-14.2%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s operating lease liabilities (current)?
Relay Therapeutics, Inc. (RLAY) reported operating lease liabilities (current) of $3.89M in Q1 2026.
How has Relay Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
Relay Therapeutics, Inc.'s operating lease liabilities (current) decreased by 34.4% year-over-year, from $5.93M to $3.89M.
What is the long-term trend for Relay Therapeutics, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 19.9% compound annual growth rate (CAGR), from $1.52M to $3.77M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.